An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

In an era where chronic diseases are reshaping global health priorities, the diabetic retinopathy market stands out as a ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 diabetes—mostly due to a lack of early screening, poor blood sugar control, and delayed ...

Regular eye exams with your optometrist can help manage diabetic retinopathy. However, if the retinopathy is severe, a ...

Diabetic retinopathy remains a major cause of vision loss among working-age individuals worldwide. While chronic ...

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

A new study by researchers at Unity Health, Sunnybrook Health Sciences Centre and the University of Toronto has found that ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will initiate a pivotal Phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical ...

Diabetic retinopathy happens when elevated blood sugar levels cause damage to the blood vessels in the retina. The retina plays a crucial role in transmitting visual images to the brain.